Archive: CD19 CAR T Cells for Relapsed ALL in Pediatric and Young Adult Patients

330 views · Published 15 October 2015 · 16:18 · Indexed 16 November 2026

Channel: UW Video · 2015 · Education

Watch on YouTube

Dr. Olivia Finney speaks at the 4th International Conference on Immunotherapy in Pediatric Oncology (CIPO2015), hosted by Seattle Children’s Research Institute.

Dr. Finney, a research scientist at Seattle Children’s Research Institute, discusses the advantages of CD19 CAR T Cell therapy over traditional treatments for pediatric and young adult patients with relapsed acute lymphoblastic leukemia.

Olivia Finney, PhD, Research Scientist, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute

09/26/2015

http://www.seattlechildrens.org/research/

http://www.seattlechildrens.org/research/childhood-cancer/CIPO-2015/

https://uw.edu/video
The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

More from this channel